NCT04316559View on ClinicalTrials.gov

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 27, 2021

Primary Completion Date

February 13, 2025

Study Completion Date

February 14, 2025

Conditions
Opioid-Use Disorder
Interventions
OTHER

Placebo

Placebo capsule

DRUG

TRV734

biased agonist at mu opioid receptors

Trial Locations (1)

21224

National Institute on Drug Abuse, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT04316559 - Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD | Biotech Hunter | Biotech Hunter